KR100589667B1 - Cosmetic composition for atopic skin containing specific plant extract - Google Patents
Cosmetic composition for atopic skin containing specific plant extract Download PDFInfo
- Publication number
- KR100589667B1 KR100589667B1 KR1020040000781A KR20040000781A KR100589667B1 KR 100589667 B1 KR100589667 B1 KR 100589667B1 KR 1020040000781 A KR1020040000781 A KR 1020040000781A KR 20040000781 A KR20040000781 A KR 20040000781A KR 100589667 B1 KR100589667 B1 KR 100589667B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- plant extract
- atopic skin
- atopic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010003645 Atopy Diseases 0.000 title claims abstract description 39
- 239000000419 plant extract Substances 0.000 title claims abstract description 31
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000006071 cream Substances 0.000 claims description 6
- -1 foundation Substances 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 5
- 239000000344 soap Substances 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 230000035876 healing Effects 0.000 abstract description 8
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000008591 skin barrier function Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract description 4
- 230000036560 skin regeneration Effects 0.000 abstract description 4
- 239000002904 solvent Substances 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000006698 induction Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 43
- 210000000434 stratum corneum Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000003251 Pruritus Diseases 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 206010012438 Dermatitis atopic Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 201000008937 atopic dermatitis Diseases 0.000 description 6
- 229940106189 ceramide Drugs 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 150000001783 ceramides Chemical class 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- IEZRNEGTKRQRFV-LFBNJJMOSA-N N-octadecanoyl-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC IEZRNEGTKRQRFV-LFBNJJMOSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229940098330 gamma linoleic acid Drugs 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 2
- 229940031352 solanine Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QXNUNZALIRZBJX-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol propane-1,2-diol propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO.OCCN(CCO)CCO QXNUNZALIRZBJX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- UZKYUEYYLCKEOD-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.[Na] Chemical compound C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.[Na] UZKYUEYYLCKEOD-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GTWVTFULHROADQ-UHFFFAOYSA-N butane-1,3-diol;ethanol;propane-1,2,3-triol Chemical compound CCO.CC(O)CCO.OCC(O)CO GTWVTFULHROADQ-UHFFFAOYSA-N 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- FWRBVROZVUCLNY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O FWRBVROZVUCLNY-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- KJXVHSUJIYXYTD-UHFFFAOYSA-N oxygen(2-) propane-1,2,3-triol titanium(4+) Chemical compound [O--].[O--].[Ti+4].OCC(O)CO KJXVHSUJIYXYTD-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- MILWSGRFEGYSGM-UHFFFAOYSA-N propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO MILWSGRFEGYSGM-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000280 sodium bentonite Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229930003352 steroid alkaloid Natural products 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B7/00—Insulated conductors or cables characterised by their form
- H01B7/04—Flexible cables, conductors, or cords, e.g. trailing cables
- H01B7/041—Flexible cables, conductors, or cords, e.g. trailing cables attached to mobile objects, e.g. portable tools, elevators, mining equipment, hoisting cables
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B7/00—Insulated conductors or cables characterised by their form
- H01B7/02—Disposition of insulation
- H01B7/0241—Disposition of insulation comprising one or more helical wrapped layers of insulation
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02G—INSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
- H02G15/00—Cable fittings
- H02G15/08—Cable junctions
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 종래의 화장료 조성물에 인체에 안전한 천연의 지부자, 용규, 명아주 등으로부터 얻은 식물추출물을 배합한 것으로서 아토피 피부의 유발을 억제함으로써 아토피 피부의 예방과 치유에 유효한 효과를 갖는 특정 식물추출물을 함유하는 아토피 피부용 화장료 조성물에 관한 것이다. The present invention is a combination of a plant extract obtained from natural branch, Yonggyu, Myeongju, etc., which is safe for the human body to a conventional cosmetic composition, and contains a specific plant extract having an effective effect on the prevention and healing of atopic skin by inhibiting the induction of atopic skin. It relates to a cosmetic composition for atopic skin.
종래의 화장료 조성물에 파괴된 피부 장벽(Skin barrier)에 대한 강한 보습 기능을 가진 천연보습인자의 강화와 더불어 표피조직이 각화되는 것을 막아주는 각화 방지제, 오염된 세균을 부작용없이 지속적으로 제거해주는 항균성분, 그리고 표피조직을 정상적으로 만들어주는 피부재생 촉진을 가지고 있으면서도 장기간 사용해도 인체 안전성이 높은 천연의 지부자, 용규, 명아주 등 특정 식물을 건조 약재를 기준하여 일정 비율로 배합하여 용매로 추출하여 얻은 식물추출물을 화장료 제형에 따라 일정량 함유하는 것으로 구성된 것이다.In addition to the strengthening of the natural moisturizing factor with a strong moisturizing function against skin barriers that are destroyed in conventional cosmetic compositions, anti-keratogenic agents that prevent the epidermal tissue from awakening, antibacterial ingredients that continuously remove contaminated bacteria without side effects And plant extracts obtained by extracting them with a solvent by mixing certain plants such as natural branch, Yonggyu, Myeongju, etc., which have high human safety even with long-term use while promoting skin regeneration that normally makes the epidermal tissue. It is composed of a certain amount according to the cosmetic formulation.
이상과 같은 본 발명에 의한 화장료 조성물의 효과를 임상적으로 측정한 결과, 본 발명에 의한 특정 식물추출물을 함유하는 아토피 피부용 화장료는 종래 처방의 화장료에 비해 아토피 피부에 대해 우수한 치유 효과를 가진다.As a result of clinically measuring the effect of the cosmetic composition according to the present invention as described above, cosmetics for atopic skin containing a specific plant extract according to the present invention has an excellent healing effect on atopic skin than the cosmetics of the conventional prescription.
지부자, 용규, 명아주, 아토피 피부Abuja, Yonggyu, Myeongju, Atopy Skin
Description
본 발명은 종래의 화장료 조성물에 인체에 안전한 천연의 지부자, 용규, 명아주 등으로부터 얻은 특정의 식물추출물을 배합한 것으로서 아토피 피부의 유발을 억제함으로써 아토피 피부의 예방과 치유에 유효한 효과를 갖는 특정 식물추출물을 함유하는 아토피 피부용 화장료 조성물에 관한 것이다. The present invention is a combination of a specific plant extract obtained from natural branch, Yonggyu, Myeongju, etc., which is safe for the human body, to a conventional cosmetic composition, and by inhibiting the induction of atopic skin, a specific plant extract having an effective effect on the prevention and healing of atopic skin. It relates to a cosmetic composition for atopic skin containing a.
일반적으로, 아토피 피부는 종전 유아기에 주로 발생하여 태열이라고도 하였으며 주로 각질층내의 세라마이드(ceramides)의 함량이 감소됨에 따라 발생하는 것으로서 각질층의 수분유지기능이 떨어짐에 따라 피부가 건조되어 각질이 쉽게 일어나며 피부장벽(skin barrier) 기능이 저하됨에 따라 자극유발물질이 각질층내로 침입하여 자극을 유발시키고 정상피부에서는 침입하기 어려운 항원 단백질이 침입함에 따라 피부 알러지 등이 용이하게 발생하여 견디기 힘들만큼의 소양증 증상을 나타낸다. 이러한 아토피 피부는 심하게 긁게 되면 습진, 켈로이드(keloid) 현상이 수반되고 심한 각질화가 일어나게 된다. 이러한 아토피 피부의 발생 원인에 대해서는 지금까지 크게 네 가지로 밝혀져 있는데, 첫째는 유전적 원인에 의한 것으로 피 부보호기능을 담당하는 피부 보호막인 세포막의 인지질과 각질세포간의 결합물질인 세포간지질을 구성하는 필수지방산인 감마-리놀레인산(γ-linoleic acid;GLA)이 부족한 상태로 인해 피부 보호막을 단단하게 만들지 못하므로 피부표면의 수분이 쉽게 소실되고 외부자극에 의해 쉽게 알러지가 발생한다는 것이며, 둘째로 환경적 요인에 의한 것으로 현대인의 주거환경의 변화로 아파트생활이 보편화되면서 생활환경이 건조한 상태로 변화됨에 따라 세계적으로 아토피 피부가 증가되고 있으며 이로 인해 수분 보유력이 저하되고 피부보호기능이 상실되어 적은 자극에도 민감하게 반응하여 알러지가 발생한다는 것이고, 세째는 활성산소에 의한 것으로 활성산소에 의해 과산화지질이 생성하게 되고 이것에 의해 아토피 피부가 발생한다는 것, 네째로 세균, 바이러스, 곰팡이에 감염되어 발생한다는 것으로서 이러한 원인들이 복합적으로 관계하여 발생한다고 보고 있다.In general, atopy skin occurs mainly in early childhood and is also called fever. It is mainly caused by a decrease in the content of ceramides in the stratum corneum. As the moisture retention function of the stratum corneum decreases, the skin dries and the keratin occurs easily. (skin barrier) As the function of the skin deteriorates, irritant substances invade the stratum corneum, causing irritation, and skin allergies easily occur as invasive antigenic proteins are difficult to invade in normal skin, resulting in the symptoms of pruritus hard to endure. Severe scratching of these atopy skin is accompanied by eczema, keloids and severe keratinization. There are four major causes of the development of atopic skin. First of all, it is caused by genetic causes, and it is composed of intercellular lipid, which is a binding material between the phospholipid and keratinocytes of the cell membrane, which is a skin protective film that is responsible for skin protection. The lack of gamma-linoleic acid (GLA), which is an essential fatty acid, does not make the skin's protective film harder, so moisture on the skin surface is easily lost and allergens are easily caused by external stimulation. Due to environmental factors, apartment life is becoming more common due to changes in the residential environment of modern people, and as the living environment is changed to a dry state, skin atopy is increasing worldwide. As a result, water retention and skin protection functions are reduced. Is sensitive to stimuli, causing allergies, and third, active Oxygen is the result of the production of lipid peroxide by oxygen, which causes atopy skin, and fourthly, it is caused by infection with bacteria, viruses, and fungi.
이러한 아토피 피부를 개선하기 위하여 원칙적으로 피부를 청결히 하여 항원으로 작용할 수 있는 물질을 제거하고 피부장벽기능을 강화하여 건조화로부터 피부를 지키기 위하여 부족한 세포간지질 성분인 세라마이드(ceramides)를 공급하며 각질층에 자극을 주지 않도록 물리적 자극을 피하는 방법을 사용해 왔다. 그래서 아토피 피부를 개선하기 위해 공지의 세라마이드, 리놀레인산, 식물유 또는 광물성 오일 등의 성분들, 하이드로코티손(hydrocortisone)과 같은 스테로이드 (steroid)제제 또는 특정의 식물추출물을 일반적인 유화제품의 처방에 함유시키거나 인지질성분인 레시틴(lecithin)을 이용하여 리포좀(liposome) 형태로 만들어 피부 각질층에 공급함으로써 보습효과 및 수분손실을 방지하기 위한 오일막을 만들어주고 세균 오염 등을 막아주기 위해 항균·항염 기능의 성분을 강화한 피부외용제 또는 화장료가 주로 사용되어 왔다.In order to improve the atopic skin, in principle, it cleans the skin, removes substances that can act as antigens, strengthens the skin barrier function, and supplies ceramides, which are insufficient intercellular lipid components, to protect the skin from drying and stimulates the stratum corneum. It has been used to avoid physical irritation. Therefore, in order to improve atopic skin, known ingredients such as ceramides, linoleic acid, vegetable oils and mineral oils, steroid preparations such as hydrocortisone or certain plant extracts may be included in the general emulsified product formulation. Or lecithin, a phospholipid component, to form a liposome and supply it to the stratum corneum to create an oil film to prevent moisturizing effect and water loss, and to prevent bacterial contamination. Fortified skin external preparations or cosmetics have been mainly used.
이러한 방법들은 아토피 피부의 예방과 치료에 있어 어느 정도 성과를 거두고 있으나 효과적인 측면이나 피부안전성 측면에 있어서 아직 몇 가지 문제점을 가지고 있다. 즉 아토피 피부용 외용제에 사용되는 스테로이드제의 사용은 표피의 성장억제나 부작용 등의 역효과를 유발할 수 있다고 보고되고 있으며 우레아 퍼록사이드 등은 피부의 자극성과 또 다른 접촉성 피부염의 우려가 항히스타민제와 같은 항생물질은 내균성의 발생과 광과민 작용의 가능성이 있다고 알려져 있다. 또한 공지의 상기생, 합환피, 창이자, 맥아, 쑥 등 종래의 동양 약재 추출물을 이용한 아토피에 유효한 화장료 조성물은 심한 소양증상(가려움증)이 해소되지 않아 계속 손으로 긁어대므로 증세의 악화가 줄어들지 않는 등 그 효능에 있어서 미미하거나 유효한 효과는 인정하지만 민감한 아토피 피부에 대해서는 경우에 따라 알레르기 과민반응을 보이는 경우도 있어 그 사용 범위가 다소 한정될 수 있는 문제점을 가지고 있다. 또한 세라마이드(ceramides)에 의한 피부 장벽의 보습 물질 강화는 아토피 피부의 다양한 피부 병증을 완전히 해소하기엔 역부족이다. 그외에 일반적인 아토피 피부용 제품에 들어가 있는 계면활성제, 향료, 알코올 등은 보호 능력이 약한 아토피 피부에는 쉽게 흡수되어 가려움을 촉진하고 아토피를 악화시킬 위험이 있다. 이러한 문제를 문제를 해결하기 위해 각질층의 수분손실에 의한 건조화를 막기 위해 세라마이드와 같은 보습제를 이용한 강한 보습막과 표피조직이 각화되는 것을 막아주는 각화방지제, 아토피성 피부염 관련 2차 세균 증식을 억제하기 위해 오염된 세균을 부작용없이 지속적으로 없애주는 항균성분, 표피조직을 정상적으로 만들어주는 피부재생 촉진제와 더불어 항염 기능과 심한 가려움증을 해소하는 제제 등이 동시에 사용되어 져야 하는 대안이 필요하게 된다. While these methods have some results in the prevention and treatment of atopic skin, there are still some problems in terms of effectiveness and skin safety. In other words, it is reported that the use of steroids used in external preparations for atopic dermatitis may cause adverse effects such as inhibition of epidermal growth and side effects. Urea peroxide, etc., has anti-histamines such as antihistamines, which may cause skin irritation and other contact dermatitis. The substance is known to have the potential for bacterial resistance and photosensitization. In addition, the cosmetic composition effective for atopic dermatitis using conventional oriental medicine extracts such as the above-mentioned raw materials, haphwanpi, changja, malt, wormwood, etc., does not resolve severe pruritus (itch) and does not reduce the deterioration of symptoms because it is continuously scratched by hand. Although the effect is insignificant or effective in its efficacy, sensitive atopy skin may have an allergic reaction in some cases, which has a problem that its use range may be somewhat limited. In addition, strengthening moisturizing substances of the skin barrier by ceramides is insufficient to completely relieve various skin conditions of atopic skin. In addition, surfactants, fragrances, alcohols, and the like contained in general atopic dermatological products are easily absorbed by the less protective atopic skin, which promotes itching and worsens atopic dermatitis. To solve this problem, in order to prevent drying of the stratum corneum due to moisture loss, a strong moisturizing membrane using a moisturizer such as ceramide, an anti-keratogenic agent to prevent the epidermal tissue from keratinizing, and to inhibit secondary bacterial growth related to atopic dermatitis. There is a need for an antimicrobial ingredient that continuously removes contaminated bacteria, a skin regeneration promoter that normally makes epidermal tissues, and an anti-inflammatory and anti-inflammatory agent that needs to be used simultaneously.
본 발명은 이러한 상기 문제점을 고려하여 안출한 것으로 아토피의 원인과 증상으로 알려져 있는 각질층의 세포간지질의 감소에 따른 각질층의 수분유지기능 저하와 피부 건조, 피부장벽(skin barrier) 기능 저하에 대해 강한 보습 기능과 표피조직이 각화되는 것을 막아주는 각화방지제, 아토피성 피부염 관련 2차 세균 증식을 억제하기 위해 오염된 세균을 부작용없이 지속적으로 없애주는 항균성분, 그리고 표피조직을 정상적으로 만들어주는 피부재생 촉진과 더불어 항염 및 항소양 기능을 가지고 있으면서 장기간 사용해도 인체 안전성이 높은 물질을 개발하기 위해 연구를 거듭한 결과, 한방 의학에서 사용되고 있으면서, 주변에서 흔히 볼 수 있는 특정의 식물추출 혼합물이 아토피 피부에 대해 유효한 효과를 가지고 있는 것을 알게 되었다. 그리하여 이들 특정 식물추출물을 종래의 화장료 조성물에 함유함으로써 아토피 피부에 유효한 효과를 갖는 화장료 조성물을 개발하게 된 바, 이를 본 발명의 실시예와 함께 상세히 설명하면 다음과 같다. The present invention has been devised in view of the above problems, a strong moisturizing effect on the water retention function of the stratum corneum and the drying of the skin, deterioration of the skin barrier function due to the reduction of intercellular lipid of the stratum corneum known to cause and symptoms of atopy In addition to the anti-keratosis agent that prevents the function and the epidermal tissue from keratinizing, the antibacterial ingredient that continuously removes the contaminated bacteria without side effects to suppress secondary bacterial growth related to atopic dermatitis, and the promotion of skin regeneration that makes the epidermal tissue normal. Research has been conducted to develop substances that have anti-inflammatory and anti-pruritic properties and are highly safe for human use even over long periods of time.As a result, certain plant extract mixtures used in herbal medicine and commonly found in the surrounding area are effective for atopic skin. I found that I have. Thus, by containing these specific plant extracts in the conventional cosmetic composition to develop a cosmetic composition having an effective effect on atopic skin, which will be described in detail with an embodiment of the present invention as follows.
종래의 화장료 조성물에 강한 보습 기능과 표피조직이 각화되는 것을 막아주는 각화방지제, 오염된 세균을 부작용없이 지속적으로 없애주는 항균성분, 그리고 표피조직을 정상적으로 만들어주는 피부재생촉진 기능과 함께 항소양 및 항염 작용을 가지고 있으면서 장기간 사용해도 인체 안전성이 높은 천연의 지부자, 용규, 명아주 등의 식물들을 건조 약재를 기준하여 일정 비율로 배합하여 용매로 추출하여 얻은 특정의 식물추출 혼합물을 화장료 제형에 따라 일정량 함유하는 것으로 구성된 것이다.Anti-pruritic and anti-inflammatory with conventional moisturizing function, anti-keratogenic agent that prevents epidermal tissue from keratinizing, antibacterial ingredient that continuously removes contaminated bacteria without side effects, and promoting skin regeneration to make epidermal tissue normally It contains a certain amount of a specific plant extract mixture obtained by extracting it with a solvent by combining a certain ratio of natural branches, yonggyu and myeongju, etc., based on dry medicinal herbs, which have a long-term use and have high human safety. It consists of.
본 발명에서 사용되는 식물들의 피부에 미치는 작용에 대해 알려진 사실을 기초로 간략히 설명하면 다음과 같다. 지부자(대싸리)는 그 씨를 받아 화단이나 공터에 뿌려 놓으면 예쁘게 잘 자라며, 예로부터 대사리는 전초 그대로나 씨(지부자)를 모아 약으로 사용해왔으며, 고서에는 지부자는 성한하고 소양 가려움증을 제거하며 방광열을 없앤다. 약효가 가장 광범위하다고 한다. 쿠마린, 사포닌, 플라보노이드, 탄닌질 등이 함유되어 있으며, 피부에는 보습효과가 있는 것으로 알려져 있다. 용규(까마중)의 검은색 열매는 지난 세대의 어린 시절, 밖에서 뛰어놀다가 풀밭에서 만나는 주전부리이기도 했다. 고서에 "용규감한, 열수를 물리치고, 절박 손상을 고치고 소변을 통리하게 한다."라고 되어 있다. 스테로이드 알칼로이드(솔라닌, 솔라니틴 등)와 미량의 아트로핀, 니코틴, 플라보노이드, 루틴, 아스파라긴, 솔라구스틴, 타닌, 시토스테린, 사포닌(리오스게닌), 유기산 등이 있다. 명아주(항학초)는 집주변 공터에서 흔히 자생하는 명아주는 그 깨끗하고 어린 잎을 따서 모아 살짝 데쳐 나물로 먹기도 하는데 약간 푸석한 느낌을 주는 별미이다. 성분과 작용으로서 로이신, 베타인, 트리고넬린 등의 아미노산, 지방산 팔미틴산, 올레이산, 리놀산 등과 비타민 A, B, C를 함유하고 있다. 히스테리, 신경쇠약, 간장 질환에도 달여서 마신다. 그리고 종창, 류마티스, 가려움증 등에 달인 물로 찜질하거나 씻는다.Briefly described based on the known facts on the action of the plants used in the present invention as follows. The branch (Sansi) grows beautifully when the seed is received and sprayed on a flower bed or vacant land.The ancient temple has gathered seeds (branches) as an outpost or used it as a medicine.In the ancient book, the branch has a good rash, removes itching, and removes bladder fever. Eliminate The drug is said to be the most extensive. It contains coumarin, saponin, flavonoids, tannins, etc., and is known to have a moisturizing effect on the skin. The black fruit of Yong-gyu was also the main beak of the past generation when he ran outside and met in the grass. The old book says, "Don't be vulnerable, to get rid of hot water, to fix impending damage and to urinate." Steroid alkaloids (solanine, solanine, etc.) and trace amounts of atropine, nicotine, flavonoids, rutin, asparagine, solagustin, tannins, cytosterins, saponins (rioosgenin), organic acids, and the like. Myeong-Aju (Hakhakcho) is a delicacy that gives a little bit of crunch, which is often grown in the empty lot around the house and picks up the clean young leaves and then boils it with herbs. It contains amino acids such as leucine, betaine and trigonelin, fatty acids palmitic acid, oleic acid, linoleic acid, and the like as vitamins A, B, and C. Hysteria, nervous breakdown, hepatic disease also decoction drink. Wash or wash with decoctions, such as swelling, rheumatism, and itching.
본 발명에 사용되는 특정 식물추출물을 제조하기 위한 식물들의 특정 배합 중량비는 건조 약재 기준으로 다음과 같다.
지부자; 60∼120g, 용규; 30∼60g, 명아주; 30∼60g
본 발명에 사용되는 식물들은 종래의 동결건조 방법으로 건조시키고 미세분말화한 후 추출한다. 본 발명에 사용되는 식물추출물을 제조하는데 이용되는 추출 용매는 정제수와 글리세린(Glycerin), 프로필렌 글리콜(Propylene Glycol), 부틸렌 글리콜(Butylene Glycol) 등과 같은 폴리올류(Polyols)의 혼합 용액이며, 추출 방법은 종래의 방법을 이용하는 것이 가능한데, 예를 들면 건조된 식물 분말에 5∼10배량의 상기 추출 용매를 가하여 1∼7일간 실온에서 침적 추출하거나 1기압하 50∼60℃에서 1∼5시간 가온 추출하여 추출물을 얻는다.
본 발명에 있어서 아토피 피부용 화장료 조성물을 피부에 바르는 외용제의 형태로 하는 경우, 피부 외용제 중의 식물 추출물의 배합량은 전체의 0.05∼50.0 중량%, 특히 0.1∼10.0 중량%로 하는 것이 좋다.
본 발명의 화장료 조성물은 상기(上記)한 특정 식물추출물 외에도 필요에 따라 본 발명의 효과를 저하시키지 않는 범위내에서 피부 외용제에 일반적으로 사용하는 각종 성분, 예를 들면 수용성 성분, 분말 성분, 유분, 계면활성제, 보습제, 점도조절제, 방부제, 산화방지제, 향료, 색소 등을 배합하는 것이 가능하다. 또한 종래의 아토피피부 치료제에 많이 사용되어온 세라마이드(Ceramides) 등 보습제 또는 지질(Lipids) 성분이나 하이드로코티손(Hydrocortisone) 등의 스테로이드 (Steroids), 레티닐 팔미테이트(Retinyl palmitate) 등의 비타민A 유도체 또는/및 토코페롤(Tocopherol), 기타 식물추출물 등을 공지의 레시틴(lecithin)을 이용하여 리포좀(liposome) 형태로 만들거나 N-스테아로일-파이토스핑고신(N-stearoyl-phytosphingosine)에 포접시켜 병용도 가능하다.
본 발명의 화장료 조성물의 제형은 임의로 선택할 수 있으되,종래의 화장료 제형인 크림, 밀크로션, 유연화장수, 팩, 파운데이션 등 뿐만 아니라, 비누, 세안폼과 같은 세안료 등 여러 가지 형태로 제조할 수 있다.
또한 본 발명에 사용되는 식물들은 오래 전부터 동양에서는 민간 요법 또는 한방에서 사용해 오던 재료로서 일정 함유량 내에서 피부 외용제로 사용시 인체에 대한 안전성이 확인되어 있어서,피부 및 점막에 대한 자극은 거의 없는 것으로 알려져 있다.
본 발명의 특정 식물추출물의 제조 방법을 실시예1을 통해 구체적으로 설명하면 다음과 같다.
<실시예1> - 본 발명에 의한 특정 식물추출물의 제조 방법
건조약재 기준으로 지부자를 분쇄한 것 100g, 용규를 분쇄한 것 50g, 명아주를 분쇄한 것 50g 등을 부틸렌 글리콜과 정제수를 각각 1:3으로 혼합한 용액 4,000㎖에 가하여 50∼60℃에서 10일간 침적하고 이를 여과, 농축하여 추출물 1,450g의 농축물을 얻었다.
또한 본 발명의 특정 식물추출물을 함유하는 아토피 피부용 화장료 조성물을 구체적인 처방예 1∼6을 통해 나타내면 아래와 같다.
<처방예 1> - 크림(Cream)
<처방예 2> - 유연화장수(Skin Toner)
<처방예 3> - 수렴 화장수(Astringent)
<처방예 4> - 밀크 로션(Milk Lotion)
<처방예 5> - 유액상 파운데이션(Liquid Foundation)
<처방예 6> - 비누(Soap)
Branch; 60 to 120 g, yonggyu; 30-60 g, quinoa; 30-60 g
Plants used in the present invention are dried by a conventional lyophilization method, and then micropowdered and extracted. The extraction solvent used to prepare the plant extract used in the present invention is a mixed solution of purified water and polyols such as glycerin, propylene glycol, butylene glycol, and the like. It is possible to use a conventional method, for example, by adding 5 to 10 times the amount of the extraction solvent to the dried plant powder, immersion extraction at room temperature for 1 to 7 days or warm extraction for 1 to 5 hours at 50 to 60 ℃ under 1 atmosphere To obtain an extract.
In the present invention, when the cosmetic composition for atopy skin is used in the form of an external preparation applied to the skin, the blending amount of the plant extract in the external preparation for skin is preferably 0.05 to 50.0% by weight, particularly 0.1 to 10.0% by weight.
The cosmetic composition of the present invention, in addition to the specific plant extracts described above, various components generally used for external preparations for skin within the scope of not lowering the effect of the present invention as necessary, for example, water-soluble components, powder components, oil, It is possible to mix | blend surfactant, a moisturizer, a viscosity modifier, a preservative, antioxidant, a fragrance | flavor, a pigment | dye, etc. In addition, vitamin A derivatives such as moisturizers such as ceramides or lipid components, steroids such as hydrocortisone, retinyl palmitate, or retinyl palmitate, which have been widely used in conventional atopic skin treatments And tocopherol (Tocopherol), and other plant extracts can be used in combination with N-stearoyl-phytosphingosine to form a liposome (liposome) using a known lecithin (N-stearoyl-phytosphingosine).
The formulation of the cosmetic composition of the present invention may be arbitrarily selected, but may be prepared in various forms such as face creams such as soap, face wash foam, as well as creams, milk lotions, soft cosmetics, packs, foundations, and the like, which are conventional cosmetic formulations. .
In addition, the plants used in the present invention have long been used in folk medicine or herbal medicine in the East for a long time, and when used as an external preparation for skin within a certain content, the safety to the human body has been confirmed, and it is known that there is little irritation to the skin and mucous membranes. .
The specific plant extract of the present invention will be described in detail with reference to Example 1 as follows.
<Example 1>-Method for producing a specific plant extract according to the present invention
Based on the dry medicine, 100g of branched ground, 50g of scallop flour, 50g of crushed malt wine were added to 4,000ml of a mixture of butylene glycol and purified water in a ratio of 1: 3. It was deposited for 1 day, filtered and concentrated to give a concentrate of 1450 g of extract.
In addition, atopy skin cosmetic composition containing a specific plant extract of the present invention is shown through the specific prescription examples 1 to 6 as follows.
<Prescription 1>-Cream
<Prescription 2>-Skin Toner
<Prescription 3>-Astringent
<Prescription 4>-Milk Lotion
<Prescription 5>-Liquid Foundation
<Prescription 6>-Soap
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
이상과 같은 본 발명에 의한 특정 식물추출물을 함유하는 아토피 피부용 화장료 조성물의 아토피 피부에 대한 치유 효과를 임상적으로 측정하기 위해 실시예1의 특정 식물추출물을 함유하는 본 발명의 화장료 조성물(처방예1)과 종래 처방의 화장료 조성물(대조용)을 크림으로 각각 제조하여 아토피 피부 보유자를 대상으로 임상 실험을 하였다. 즉, 6세∼50세 분포의 단순 아토피 피부를 가진 사람 25명과 아토피성 피부 염증을 가진 사람 15명이 남녀 비율 29 : 11로 구성된 피실험자를 대상으로 상기 2가지 크림을 매일 2∼3회, 15일간 사용하면서 가려움증 해소, 각질층 보습 및 보호막 형성(장벽회복), 표피층 신진대사 정상화, 염증 치유 등의 아토피 치유 상태를 육안으로 관찰하여 그 효과를 판정하여 표2와 같은 결과를 얻었다.
<표 2> - 아토피 치유 효과
또한 본 발명에 의한 화장료 조성물의 아토피 치유 효과는 표2에 나타난 바와 같이 매우 양호한 것으로 판명되었다. 이러한 모든 결과를 두고 볼 때, 본 발명에 의한 특정 식물추출물을 함유하는 아토피 피부용 화장료는 종래 처방의 화장료에 비해 아토피 피부에 대해 우수한 치유 효과를 가진다.Cosmetic composition of the present invention containing the specific plant extract of Example 1 in order to clinically measure the healing effect of the atopic skin cosmetic composition containing a specific plant extract according to the present invention as described above atopic skin (prescription example 1 ) And the cosmetic composition of the conventional prescription (control) were prepared as a cream, respectively, and clinical trials were carried out for atopic skin holders. That is, 25 people with simple atopic skin with a distribution of 6 to 50 years old and 15 people with atopic dermatitis were treated with the two creams 2 to 3 times daily for 15 days. During use, atopic dermatological conditions such as relieving itching, stratum corneum hydration and protective film formation (barrier recovery), normalization of epidermal metabolism, and inflammation healing were visually observed, and the effects thereof were determined to obtain the results shown in Table 2.
<Table 2>-Atopic Healing Effect
In addition, the atopy healing effect of the cosmetic composition according to the present invention was found to be very good as shown in Table 2. In view of all these results, atopic dermatological cosmetics containing certain plant extracts according to the present invention have a superior healing effect on atopic skin than conventional cosmetics.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040000781A KR100589667B1 (en) | 2004-01-06 | 2004-01-06 | Cosmetic composition for atopic skin containing specific plant extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040000781A KR100589667B1 (en) | 2004-01-06 | 2004-01-06 | Cosmetic composition for atopic skin containing specific plant extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050072378A KR20050072378A (en) | 2005-07-11 |
KR100589667B1 true KR100589667B1 (en) | 2006-06-14 |
Family
ID=37261855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040000781A Expired - Fee Related KR100589667B1 (en) | 2004-01-06 | 2004-01-06 | Cosmetic composition for atopic skin containing specific plant extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100589667B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100897140B1 (en) | 2009-01-23 | 2009-05-14 | 주식회사 더마랩 | Mixed extract of natural plants and cosmetic composition containing the same |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100829717B1 (en) * | 2006-09-14 | 2008-05-15 | 주식회사 코리아나화장품 | Converging cosmetic composition containing fruit extract as active ingredient |
KR100867509B1 (en) * | 2007-05-07 | 2008-11-10 | 김혁 | Mask pack containing branch extract and its manufacturing method |
KR101587870B1 (en) * | 2008-11-28 | 2016-01-22 | (주)아모레퍼시픽 | Composition for reducing irritation and inflammation in skin |
KR101389970B1 (en) * | 2012-08-24 | 2014-04-30 | 원광대학교산학협력단 | A composition comprising ponciri fructus showing lipogenic effect |
-
2004
- 2004-01-06 KR KR1020040000781A patent/KR100589667B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100897140B1 (en) | 2009-01-23 | 2009-05-14 | 주식회사 더마랩 | Mixed extract of natural plants and cosmetic composition containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20050072378A (en) | 2005-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101146206B1 (en) | Cosmetic Composition And Composition of Skin External Application | |
KR101236946B1 (en) | Cosmetic Composition Comprising Naturalplant Extract for Alleviating Atopic Dermatitis | |
KR101315265B1 (en) | Cosmetic composition for improving skin senescence | |
KR101471818B1 (en) | Cosmetic composition for alleviating dermatitis and skin irritation | |
KR101284656B1 (en) | Cosmetic Composition | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
JPH0761916A (en) | External agent for skin | |
KR20200057677A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
KR20170103172A (en) | Cosmetic compositions containing centella asiatica extract, ceramide and betula alba juice for relieving skin irritation and reinforcing skin barrier | |
KR100517465B1 (en) | Compositions of cosmetics for atopy skin containing oriental herbal extracts | |
KR100633380B1 (en) | Herbal cosmetic composition for atopic skin containing specific herbal extract mixture | |
KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
KR100589667B1 (en) | Cosmetic composition for atopic skin containing specific plant extract | |
KR101763736B1 (en) | Composition for moisturizing skin containing extracts prepared by enzyme process | |
KR101934976B1 (en) | Composition for enhancing skin barrier comprising mixture of Diospyros lotus leaf extract and Curcuma longa extract as effective component | |
KR101987420B1 (en) | Cosmetic composition for skin moisturizing and skin soothing comprising dioscorea villosa, sesame indicum, saussurea involucrata and lonicera japonica extract | |
KR20200108207A (en) | A method for extracting fat soluble solvent of Loquat leaf (Eriobotrya japonica Lindley) and Taraxaci Herba(Taraxacum platycarpum) for use as a cosmetic composition | |
KR20160003920A (en) | Cosmetic composition for anti-inflammation or improving skin trouble containing herb extracts | |
JP2022132237A (en) | Multipurpose beauty essence | |
KR101866518B1 (en) | A cosmetic composition for manufacturing by the using of propolis improving onychomycosis | |
KR100900197B1 (en) | Skin external preparation composition for inhibiting skin immunity containing specific plant extract mixture | |
KR101954662B1 (en) | Anti-itching cosmetic composition | |
KR102782317B1 (en) | Cosmetic composition having an atopic improvement effect | |
KR101769123B1 (en) | Cosmetic composition containing natural complex extract for improving atopic dermatitis | |
KR102827888B1 (en) | Cosmetic composition containing oriental medicine extraction mixture comprising ulmus davidiana, lithospermum erythrorhizon, chrysanthemum incidicum linne and manufacturing methods thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040106 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20051018 Patent event code: PE09021S01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060112 Patent event code: PE09021S01D |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20060316 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20060518 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20060607 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20060608 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |